期刊
BIOACTIVE MATERIALS
卷 2, 期 4, 页码 224-247出版社
KEAI PUBLISHING LTD
DOI: 10.1016/j.bioactmat.2017.05.007
关键词
Fracture healing; Bone grafts and substitutes; Growth factors; Bioinorganic ions
资金
- Shenzhen Science and Technology Innovation Funding [JCYJ20140414090541811, JCYJ20160429190821781, JCYJ2016429185449249]
- Hong Kong Research Grant Council General Research Funds (RGC GRF) [718913E, 17214516, N_HKU725/16]
- HKU Seeding Fund [201511160001, 201411159045]
- Hong Kong Innovation Technology Fund [ITS/147/15]
- Hong Kong Health and Medical Research Fund [03142446]
- National Natural Science Foundation of China (NSFC) [31370957]
Bone grafts have been predominated used to treat bone defects, delayed union or non-union, and spinal fusion in orthopaedic clinically for a period of time, despite the emergency of synthetic bone graft substitutes. Nevertheless, the integration of allogeneic grafts and synthetic substitutes with host bone was found jeopardized in long-term follow-up studies. Hence, the enhancement of osteointegration of these grafts and substitutes with host bone is considerably important. To address this problem, addition of various growth factors, such as bone morphogenetic proteins (BMPs), parathyroid hormone (PTH) and platelet rich plasma (PRP), into structural allografts and synthetic substitutes have been considered. Although clinical applications of these factors have exhibited good bone formation, their further application was limited due to high cost and potential adverse side effects. Alternatively, bioinorganic ions such as magnesium, strontium and zinc are considered as alternative of osteogenic biological factors. Hence, this paper aims to review the currently available bone grafts and bone substitutes as well as the biological and bio-inorganic factors for the treatments of bone defect. (C) 2017 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据